No |
Applicant Date |
Invention Title |
Applicants |
Condition |
33 |
2021 |
A Contrast Agent Composition for Detecting Lesional Margin of Dementia Caused by Degenerative Brain Disease Comprising Quinoline Derivatives as Active Ingredients |
PCT |
Pending application |
32 |
2020 |
A Contrast Agent Composition for Detecting Lesional Margin of Dementia Caused by Degenerative Brain Disease Comprising Quinoline Derivatives as Active Ingredients |
KOREA |
Pending application |
31 |
2021 |
A Contrast Agent Composition for Detecting Lesional Margin of Astrocytosis-Related Disease Comprising Quinoline Derivatives as Active Ingredients |
PCT |
Pending application |
30 |
2020 |
A Contrast Agent Composition for Detecting Lesional Margin of Astrocytosis-Related Disease Comprising Quinoline Derivatives as Active Ingredients |
KOREA |
Patent registration |
29 |
2021 |
A Contrast Agent Composition for Detecting Lesional Margin of Dementia Caused by Degenerative Brain Disease Comprising C11-Acetate as an Active Ingredient |
PCT |
Pending application |
28 |
2020 |
A Contrast Agent Composition for Detecting Lesional Margin of Dementia Caused by Degenerative Brain Disease Comprising C11-Acetate as an Active Ingredient |
KOREA |
Pending application |
27 |
2020 |
Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) |
KOREA |
Patent registration |
26 |
2020 |
Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) |
KOREA |
Pending application |
25 |
2020 |
Neural Plasticity Control Device and Method Using Theta-Burst Ultrasound |
KOREA |
Pending application |
24 |
2021 |
Modified CRY2 with high photosensitivity and use of the same |
U.S.A |
Pending application |